Drug Pipeline

CLR 131 Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
3
Active Studies
1
Recruiting
1
Top Sponsors
Active Studies by Phase
Phase 1
3
Active Trials
NCT IDTitleConditionStatus
Phase 1
NCT07311993 Phase 1 Study of CLR 125 in Triple Negative Breast Cancer Breast Cancer Recruiting
NCT03478462 Dose Escalation Study of CLR 131 in Pediatric Relapsed/Refractory Malignant Tumors… Pediatric Solid Tumor Active, Not Recruiting
NCT05610891 Novel Targeted Radiotherapy in Pediatric Patients With Inoperable Relapsed or Refractory… High-Grade Glioma Active, Not Recruiting
Sponsors Running CLR 131 Trials
Cellectar Biosciences, Inc. (3)
Disease Areas
Sarcoma (1) Glioma (1) Breast Cancer (1)
Get alerts when CLR 131 trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free